Abstract
We would like to thank Dr Efthimiadis, and his colleagues for their interest in our study1 and their critical reflection on the relationship between surgical myectomy and implantable-cardioverter defibrillator (ICD) discharge in hypertrophic cardiomyopathy (HCM). The surgical myectomy has been demonstrated to be the ‘gold-standard’ in therapy for those symptomatic patients with drug-refractory HCM with significant outflow tract obstruction. Although significant improvements in haemodynamics, symptoms, morbidity, and mortality have been …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
